Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 891 |
|
|||||
| News | - | ||||||
| Day High | 4.31 | Low High |
|||||
| Day Low | 4.265 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| SAB Biotherapeutics Inc | SABS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.17 | -3.81% | 4.29 | 16:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.265 | 4.265 | 4.31 | 4.29 | 4.46 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 45 | 891 | $ 4.31 | $ 3,840 | - | 4.00 - 11.90 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:05 | 33 | $ 4.29 | USD |
SAB Biotherapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 39.76M | 9.23M | - | 2.24M | -42.19M | -4.57 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
SAB Biotherapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SABS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.61 | 4.94 | 4.265 | 4.69 | 4,010 | -0.32 | -6.94% |
| 1 Month | 4.67 | 4.95 | 4.00 | 4.40 | 5,784 | -0.38 | -8.14% |
| 3 Months | 5.88 | 6.30 | 4.00 | 5.20 | 14,992 | -1.59 | -27.04% |
| 6 Months | 6.90 | 10.50 | 4.00 | 7.90 | 40,689 | -2.61 | -37.83% |
| 1 Year | 9.282 | 11.90 | 4.00 | 8.52 | 110,942 | -4.99 | -53.78% |
| 3 Years | 78.00 | 120.90 | 3.657 | 25.80 | 236,721 | -73.71 | -94.50% |
| 5 Years | 78.00 | 120.90 | 3.657 | 25.80 | 236,721 | -73.71 | -94.50% |
SAB Biotherapeutics Description
| SAB Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing fully human, multi-targeted, high-potency immunoglobulins (IgGs), without the need for human donors or convalescent plasma, to treat and prevent immune and autoimmune disorders. The company's lead asset, SAB-142, targets Type-1 diabetes (T1D) with a disease-modifying therapeutic approach that aims at changing the treatment paradigm by delaying onset and potentially preventing disease progression. |
